Case Report
Copyright ©2010 Baishideng. All rights reserved
World J Gastroenterol. Mar 7, 2010; 16(9): 1150-1154
Published online Mar 7, 2010. doi: 10.3748/wjg.v16.i9.1150
Hepatic arterial infusion of gemcitabine-oxaliplatin in a large metastasis from colon cancer
Boris Guiu, Julie Vincent, Séverine Guiu, Sylvain Ladoire, Pablo Ortega-Deballon, Jean-Pierre Cercueil, Bruno Chauffert, François Ghiringhelli
Boris Guiu, Jean-Pierre Cercueil, Department of Radiology, INSERM U866, University of Burgundy, University Hospital, Dijon, BP 87900 F-21079, France
Julie Vincent, Department of Hepatology, INSERM U866, University of Burgundy, University Hospital, Dijon, BP 87900 F-21079, France
Séverine Guiu, Sylvain Ladoire, Bruno Chauffert, François Ghiringhelli, Department of Oncology, INSERM U866, AVENIR Team, University of Burgundy, Georges-François Leclerc Cancer Center, Dijon, BP 87900 F-21000, France
Pablo Ortega-Deballon, Department of Digestive Surgery, INSERM U866, University of Burgundy, University Hospital, Dijon, BP 87900 F-21079, France
Author contributions: All authors contributed to the manuscript; Guiu B and Ghiringhelli F supervised the work.
Correspondence to: Boris Guiu, MD, Department of Radiology, INSERM U866, University of Burgundy, University Hospital, Dijon, BP 87900 F-21079, France. boris.guiu@chu-dijon.fr
Telephone: +33-380-293686 Fax: +33-380-295455
Received: September 1, 2009
Revised: October 22, 2009
Accepted: October 29, 2009
Published online: March 7, 2010
Abstract

Hepatic arterial infusion (HAI) of chemotherapy can be performed in cases of liver-confined metastatic disease, resulting in increased local drug concentrations. Here we report the case of a 61-year-old man who presented with an isolated large unresectable liver metastasis of colon cancer after failure of surgery and multiple administration of systemic chemotherapy. The patient was treated with a combination of gemcitabine and oxaliplatin using HAI. The tolerance was excellent and a radiological complete response was obtained after 8 cycles of HAI. The rationale for the use of gemcitabine and oxaliplatin as well as that for the combination of the 2 drugs is discussed in this paper. HAI of gemcitabine-oxaliplatin should be evaluated in further clinical trials.

Keywords: Hepatic artery; Chemotherapy; Colon cancer; Liver metastasis; Gemcitabine; Oxaliplatin; Contrast media; Computed tomography